drugset / Trial / NCT06098456

Epigallocatechin Gallate and Other Antural Compounds in HPV Infections

NCT06098456

Phase 2 Completed 178 enrolled Centro di Ricerca Clinica Salentino
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The investigators enroll patients with a PAP-test cytology reporting LSIL or ASCUS. Pateitns undergo HPV-DNA test for screening. Patients are treated with Epigallocatechin galalte, hyaluronic acid, folic acid and Vitamin B12 by oral route. After three months of treatment PAP-test and HPV-DNA test will be repeated.

Timeline

Start
2023-11-01
Primary completion
2024-05-15
Completion
2024-06-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Epigallocatechin gallate Small molecule 200 mg Oral
Subject Hyaluronic Acid Other / unclassified 50 mg Oral
Subject Vitamin B12 Other / unclassified 1 mg Oral
Subject folic acid Other / unclassified 400 ug Oral

Indications